Glycyrrhetinic acid as a hepatocyte targeting unit for an anticancer drug delivery system with enhanced cell type selectivity

  • Hardev Singh
  • , Seo Jin Kim
  • , Dong Hoon Kang
  • , Hye Ri Kim
  • , Amit Sharma
  • , Won Young Kim
  • , Chulhun Kang
  • , Jong Seung Kim

    Research output: Contribution to journalArticlepeer-review

    30 Citations (Scopus)

    Abstract

    Herein, we report the potential of glycyrrhetinic acid (GA) as an active targeting ligand for hepatocellular carcinoma (HCC) for the development of diagnosis/therapy using small-molecule based approaches. Our preliminary results demonstrated that GA-conjugation to diagnostic/therapeutic counterparts significantly enhanced their HCC targeting ability and excellent therapeutic efficacy.

    Original languageEnglish
    Pages (from-to)12353-12356
    Number of pages4
    JournalChemical Communications
    Volume54
    Issue number87
    DOIs
    Publication statusPublished - 2018

    Bibliographical note

    Publisher Copyright:
    © The Royal Society of Chemistry.

    ASJC Scopus subject areas

    • Electronic, Optical and Magnetic Materials
    • Ceramics and Composites
    • Metals and Alloys
    • Materials Chemistry
    • Surfaces, Coatings and Films
    • General Chemistry
    • Catalysis

    Fingerprint

    Dive into the research topics of 'Glycyrrhetinic acid as a hepatocyte targeting unit for an anticancer drug delivery system with enhanced cell type selectivity'. Together they form a unique fingerprint.

    Cite this